Suppr超能文献

近红外高光谱成像结合多元分析实时测定和可视化药物片剂制造过程中的两个独立参数。

Real-time determination and visualization of two independent quantities during a manufacturing process of pharmaceutical tablets by near-infrared hyperspectral imaging combined with multivariate analysis.

机构信息

Department of Engineering Science, Osaka Electro-Communication University, 18-8 Hatsucho, Neyagawa 572-8530, Japan; Technology Department, Mitsubishi Tanabe Pharma Factory, 955, Koiwai, Yoshitomi-cho, Chikujo-gun, Fukuoka 871-8550, Japan.

Technology Department, Mitsubishi Tanabe Pharma Factory, 955, Koiwai, Yoshitomi-cho, Chikujo-gun, Fukuoka 871-8550, Japan.

出版信息

Int J Pharm. 2020 Nov 30;590:119871. doi: 10.1016/j.ijpharm.2020.119871. Epub 2020 Sep 25.

Abstract

During pharmaceutical manufacturing, line-scan hyperspectral imaging enables us to collect several electromagnetic spectra at each pixel in a two-dimensional plane for each tablet. The present study quantitatively determines two independent values of the active pharmaceutical ingredient (API) content in a tablet and the amount of coating on a surface of the same tablet simultaneously; the process is visualized by means of a near-infrared hyperspectral imaging (NIR-HSI) system combined with multivariate data analysis at a typical manufacturing speed of 4,000 tablets per minute. The API content and the amount of coating were controlled to be in the range 80-120% and 0-7 mg, respectively. The results of the cross validation of regression models demonstrated a coefficient of determination (R) of 0.942, a root-mean-square error of cross validation (RMSECV) of 3.48% for the API content, an R of 0.939, and an RMSECV of 0.46 mg for the amount of coating. These results demonstrated that the API content in a tablet as well as the amount of coating on the surface of the same tablet can be simultaneously determined with sufficient accuracy. This technique is practically applicable to process analytical technology in pharmaceutical manufacturing.

摘要

在制药生产过程中,线扫描高光谱成像使我们能够在每个片剂的二维平面中的每个像素处收集多个电磁光谱。本研究定量确定了片剂中活性药物成分 (API) 含量和同一片剂表面涂层量的两个独立值;通过近红外高光谱成像 (NIR-HSI) 系统与多元数据分析相结合,以典型的每分钟 4000 片的制造速度实现了可视化。API 含量和涂层量分别控制在 80-120%和 0-7mg 的范围内。回归模型交叉验证的结果表明,API 含量的决定系数 (R) 为 0.942,交叉验证均方根误差 (RMSECV) 为 3.48%,涂层量的 R 为 0.939,RMSECV 为 0.46mg。这些结果表明,可以以足够的精度同时确定片剂中的 API 含量以及同一片剂表面的涂层量。该技术在制药生产中的过程分析技术中具有实际应用价值。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验